Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Subscribe To Our Newsletter & Stay Updated
